Among the shares expected to see active trade in Thursday's session are Aetna, Campbell Soup, Hot Topic, Jack in the Box, Limited, NetApp, Sears, Sony and Stage Stores.

The world's top largest pharmaceutical firm is reported planning to release generic drugs in Japan as early as 2011, expecting demand to increase amid efforts to control drug prices.

Vivus (VVUS) is raising the bar on erectile dysfunction drugs potentially becoming the latest formidable competitor to Viagra and Cialis in the $3.8 billion market. Investors in the California-based pharmaceutical company jumped on Wednesday when the company cited positive results from a late-stage study of its erectile dysfunction drug avanafil. The stock shot up almost 6% in early morning trading while shares of Pfizer (PFE) which makes Viagra and Eli Lilly (LLY) maker of Cialis remained relatively flat. Vivus announced the results from its phase 3 Revive study which tested the safety and efficacy of avanafil for the treatment ...

Investing as if the markets can only go up is a recipe for disaster, while embracing pessimism will keep you in the game.

Drug stocks slip early Wednesday, while shares of Vivus jump on a positive Phase III clinical study for the company’s new erectile-dysfunction drug.

Data Show Geodon Used as an Adjunct to Lithium or Valproate Is Effective in the Maintenance Treatment of Bipolar I Disorder

Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations

Advisory Committee Also Reaffirms the Product’s Safety Profile

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.